Read more

November 22, 2019
1 min read
Save

Will Smith gets a colonoscopy — should patients use a low-residue diet for theirs? Read the week’s top stories in gastroenterology

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A video Will Smith recently posted about his colonoscopy in which he walked viewers through the entire process earned praise from physicians for helping to normalize the procedure. It was the week’s top story in gastroenterology.

Another top story was about a study presented at the American College of Gastroenterology Annual Meeting that found patients who adhered to a single-day, low-residue diet had better bowl prep and tolerance than those with a clear liquid diet.

‘Everyone needs to see this’: Will Smith gets a colonoscopy

In West Philadelphia, born and raised, in the endo suite is where Will Smith spent most of his day in August as he underwent his first colonoscopy. Smith, who turned 50 last year, was getting screened for colorectal cancer for the first time, but, unlike most people, he decided to share his experience by posting a vlog on his YouTube page. Read more.

Low-residue diet improves bowel prep, patient tolerance

Patients who adhered to a single-day, low-residue diet prior to colonoscopy had a better bowel preparation and reported better tolerance compared with a clear liquid diet, according to study results presented at the American College of Gastroenterology Annual Meeting. Read more.

Underwater endoscopic mucosal resection viable alternative to conventional treatment

Underwater endoscopic mucosal resection was a safe and effective alternative to conventional resection in patients with large laterally spreading colorectal tumors, according to study results presented at the American College of Gastroenterology Annual Meeting. Read more.

AI identifies pathogenesis pathways, risk for Crohn’s disease

AVA,Dx, a machine learning method for risk prediction of Crohn’s disease, revealed new potential CD genes and accurately identified the disease in a group of more than 3,000 individuals, according to a recent study. Read more.

VIDEO: Endoscopic therapy for GERD in the ‘best position it’s ever been’

In this exclusive video from the American College of Gastroenterology Annual Meeting, Ronnie Fass, MD, FACG, medical director of the digestive health center at MetroHealth Medical Center in Cleveland, discusses endoscopic therapies for patients with GERD. Read more.